Annovis Bio, Inc. (ANVS) Tops Q2 EPS by 8c

Annovis Bio, Inc. (NYSE: ANVS) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results